Logo (Actavis) 3117 Logo (Actavis) 3117 Pill - brown capsule/oblong, 20mm
Pill with imprint Logo (Actavis) 3117 Logo (Actavis) 3117 is Brown, Capsule/Oblong and has been identified as Morphine Sulfate Extended-Release 75 mg. It is supplied by Actavis Elizabeth LLC.
Morphine is used in the treatment of Chronic Pain; Neonatal Abstinence Syndrome; Pain and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Morphine 75 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for Logo (Actavis) 3117 Logo (Actavis) 3117
Morphine Sulfate Extended-Release
- Imprint
- Logo (Actavis) 3117 Logo (Actavis) 3117
- Strength
- 75 mg
- Color
- Brown
- Size
- 20.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Actavis Elizabeth LLC
- National Drug Code (NDC)
- 00228-3117
- Inactive Ingredients
-
diethyl phthalate,
ethylcellulose,
gelatin,
methacrylic acid - methyl methacrylate copolymer (1:1),
polyethylene glycol,
sucrose,
magnesium silicate,
titanium dioxide,
ferrosoferric oxide,
ferric oxide red,
ferric oxide yellow,
butyl alcohol,
alcohol,
isopropyl alcohol,
potassium hydroxide,
propylene glycol,
water,
shellac,
ammonia
Note: Inactive ingredients may vary.
See also:
More about morphine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (367)
- Drug images
- Latest FDA alerts (12)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
Other brands
MS Contin, Roxanol, Duramorph, Kadian, ... +10 more
Professional resources
- Morphine Sulfate monograph
- Morphine ER (FDA)
- Morphine Extended Release Capsules (FDA)
- Morphine Injection (FDA)
- Morphine Oral Solution (FDA)
Other brands
MS Contin, Duramorph, Kadian, Astramorph PF, ... +4 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.